BioNexus Gene Lab Corp: Form 10-K/A for the period ended Dec 31, 2024
Filed with the SEC on Apr 29, 2025 and accepted by EDGAR at Apr 29, 2025, 19:22 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Shares outstanding | At period end2024-12-31 | 17,967,663 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001477932-25-003062. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.